Pregnancy in Parkinson’s disease: case report and discussion

Abstract

Pregnancy in Parkinson’s disease (PD) is an uncommon occurrence. Available reports suggest that there may be a worsening of PD symptom severity related to pregnancy. In this special report, medical literature on pregnancy in PD will be reviewed with regard to disease progression and the safety of antiparkinsonian medications. A case report of pregnancy in a woman with PD will be described. It is speculated that the symptoms of PD may be affected by changing hormone levels.

Keywords::

• amantadine
• COMT inhibitor
• dopamine agonist
• estrogen
• levodopa
• MAO-B inhibitor
• Parkinson’s disease
• pregnancy
• progression

Financial & competing interests disclosure

Data collection and analysis were funded by the Rosalyn Newman Foundation. B Robottom reports no financial conflicts of interest. L Shulman has received consulting fees or honoraria from Boehringer-Ingelheim, Kyowa, Novartis and Teva Pharmaceuticals. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.